Literature DB >> 12795654

Angiotensin converting enzyme inhibitors and modulation of skeletal muscle insulin resistance.

E J Henriksen1, S Jacob.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12795654     DOI: 10.1046/j.1463-1326.2003.00265.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


× No keyword cloud information.
  17 in total

Review 1.  Metabolic actions of angiotensin receptor antagonists: PPAR-gamma agonist actions or a class effect?

Authors:  Paul Ernsberger; Richard J Koletsky
Journal:  Curr Opin Pharmacol       Date:  2007-02-15       Impact factor: 5.547

Review 2.  Lewis K. Dahl memorial lecture: the renin-angiotensin system and aging.

Authors:  Debra I Diz
Journal:  Hypertension       Date:  2008-05-12       Impact factor: 10.190

3.  Low plasma level of atrial natriuretic peptide predicts development of diabetes: the prospective Malmo Diet and Cancer study.

Authors:  Martin Magnusson; Amra Jujic; Bo Hedblad; Gunnar Engström; Margaretha Persson; Joachim Struck; Nils G Morgenthaler; Peter Nilsson; Christopher Newton-Cheh; Thomas J Wang; Olle Melander
Journal:  J Clin Endocrinol Metab       Date:  2011-11-23       Impact factor: 5.958

Review 4.  ACE inhibitors and angiotensin receptor antagonists and the incidence of new-onset diabetes mellitus: an emerging theme.

Authors:  David Aguilar; Scott D Solomon
Journal:  Drugs       Date:  2006       Impact factor: 9.546

5.  Opposing effects of β blockers and angiotensin-converting enzyme inhibitors on development of new-onset diabetes mellitus in patients with stable coronary artery disease.

Authors:  Orly Vardeny; Hajime Uno; Eugene Braunwald; Jean Lucien Rouleau; Bernard Gersh; Aldo P Maggioni; Michael Domanski; Marc A Pfeffer; Scott D Solomon
Journal:  Am J Cardiol       Date:  2011-04-18       Impact factor: 2.778

Review 6.  Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.

Authors:  André J Scheen
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Inhaled insulin is associated with prolonged enhancement of glucose disposal in muscle and liver in the canine.

Authors:  Dale S Edgerton; Alan D Cherrington; Doss W Neal; Melanie Scott; Margaret Lautz; Nancy Brown; Jeff Petro; Charles H Hobbs; Chet Leach; Angelo Del Parigi; Thomas R Strack
Journal:  J Pharmacol Exp Ther       Date:  2008-12-19       Impact factor: 4.030

8.  The Novel Angiotensin II Receptor Blocker Azilsartan Medoxomil Ameliorates Insulin Resistance Induced by Chronic Angiotensin II Treatment in Rat Skeletal Muscle.

Authors:  Guido Lastra; Fernando R Santos; Payam Hooshmand; Paria Hooshmand; Irina Mugerfeld; Annayya R Aroor; Vincent G Demarco; James R Sowers; Erik J Henriksen
Journal:  Cardiorenal Med       Date:  2013-06-25       Impact factor: 2.041

Review 9.  Antihypertensive medications: benefits of blood pressure lowering and hazards of metabolic effects.

Authors:  Jason H Karnes; Rhonda M Cooper-DeHoff
Journal:  Expert Rev Cardiovasc Ther       Date:  2009-06

10.  B-type natriuretic peptide levels and insulin resistance in patients with severe ischemic myocardial dysfunction.

Authors:  F Tassone; L Gianotti; F Rolfo; G Visconti; G Borretta; M Feola
Journal:  J Endocrinol Invest       Date:  2009-03-25       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.